1Health.io has partnered with EHE Health to deliver saliva-based Covid-19 tests to self-insured employers in the US. EHE Health aims to provide resting kits to the clients which will allow them to deploy on-site testing portals. These measures are expected to lead to a safer work environment and will support the employees as they return to their workplace.

Avacta Group has announced that the BAMS assay that is used to identify the SARS-CoV-2 virus is being provided as a research kit by Adeptrix. Additionally, Bruker Scientific has presented the assay in a new application note. The bead-assisted mass spectrometry (BAMS) assay can be used by a technician to analyse up to 1,000 samples each day, providing a high throughput technique for the diagnosis and research of Covid-19.

BD’s rapid, point-of-care, SARS-CoV-2 antigen test that is designed to be used on the BD Veritor Plus System has received the CE mark to the IVD Directive (98/79/EC). Capable of providing results in 15 minutes, the test delivers the results on a portable instrument. This is said to be beneficial for the turnaround time for Covid-19 diagnostics, as results are available when the patient is still present on the testing site.

Health Canada has approved Vexos’ Mechanical Ventilator Milano (MVM) ventilator under its Interim Order. This May, the company signed a contract with the Canadian Government for the manufacture and supply of around 10,000 MVM units. Vexos plans to commence the shipping the MVM ventilators to Canada.